Biotech Stock News (CMRX) (PTCT) (SRPT) (BMRN) (PPHM)

Chimerix (NASDAQ:CMRX)  On Monday February 22, 2016 shares of Chimerix tumbled by 40% as the company announced that two phase 3 trials had to be stopped because of lack of efficacy. The phase 3 trial, known as the SUPPRESS trial, recruited a total of 452 patients. The patients that were recruited in the trial were … Read more

Biotech Stock News (KBIO) (RTRX) (CMRX)

Kalobios (NASDAQ:KBIO) On Tuesday December 29, 2015 Kalobios made an SEC filing whereby the company filed for Chapter 11 Bankruptcy. This does not mean that the company is going bankrupt, instead it signifies that the company needs to put its functions on hold until it can develop a proper restructuring plan. This filing occurred in … Read more